ClinicalTrials.gov
ClinicalTrials.gov Menu

AZD2171 and Temsirolimus in Patients With Advanced Gynecological Malignancies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01065662
Recruitment Status : Active, not recruiting
First Posted : February 9, 2010
Last Update Posted : July 27, 2018
Sponsor:
Collaborators:
Massachusetts General Hospital
Beth Israel Deaconess Medical Center
National Comprehensive Cancer Network
Wyeth is now a wholly owned subsidiary of Pfizer
AstraZeneca
Information provided by (Responsible Party):
Susana M. Campos, MD, Dana-Farber Cancer Institute

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : September 2013
  Estimated Study Completion Date : December 2018